Found: 15
Select item for more details and to access through your institution.
Corrigendum: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 4, p. 378, doi. 10.1038/nbt.1532
- By:
- Publication type:
- Article
A Mass Spectrometric-Derived Cell Surface Protein Atlas.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0121314
- By:
- Publication type:
- Article
PASSEL: The Peptide Atlas SRMexperiment library.
- Published in:
- Proteomics, 2012, v. 12, n. 8, p. 1170, doi. 10.1002/pmic.201100515
- By:
- Publication type:
- Article
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0259093
- By:
- Publication type:
- Article
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0233442
- By:
- Publication type:
- Article
Evaluation of Proclarix in the diagnostic work‐up of prostate cancer.
- Published in:
- BJUI Compass, 2024, v. 5, n. 2, p. 297, doi. 10.1002/bco2.293
- By:
- Publication type:
- Article
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.
- Published in:
- BJUI Compass, 2020, v. 1, n. 1, p. 15, doi. 10.1002/bco2.8
- By:
- Publication type:
- Article
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
- Published in:
- BJU International, 2023, v. 132, n. 2, p. 188, doi. 10.1111/bju.15998
- By:
- Publication type:
- Article
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
- Published in:
- BJU International, 2023, v. 132, n. 2, p. 188, doi. 10.1111/bju.15998
- By:
- Publication type:
- Article
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.
- Published in:
- BJU International, 2019, v. 123, n. 5, p. 826, doi. 10.1111/bju.14540
- By:
- Publication type:
- Article
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.
- Published in:
- Prostate, 2022, v. 82, n. 15, p. 1469, doi. 10.1002/pros.24422
- By:
- Publication type:
- Article
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0181557
- By:
- Publication type:
- Article
Targeted proteomic strategy for clinical biomarker discovery
- Published in:
- Molecular Oncology, 2009, v. 3, n. 1, p. 33, doi. 10.1016/j.molonc.2008.12.001
- By:
- Publication type:
- Article
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.
- Published in:
- Clinical Proteomics, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12014-022-09349-x
- By:
- Publication type:
- Article